Skip to main content

Month: June 2020

American Airlines Group Announces Proposed Offerings of Common Stock and Convertible Senior Notes Due 2025

FORT WORTH, Texas, June 21, 2020 (GLOBE NEWSWIRE) — American Airlines Group Inc. (NASDAQ: AAL) (the “Company”) today announced proposed underwritten public offerings of $750,000,000 of shares of its common stock (the “Common Stock” and, such offering, the “Common Stock Offering”) and $750,000,000 aggregate principal amount of its convertible senior notes due 2025 (the “Convertible Notes” and such offering, the “Convertible Notes Offering”).The Company intends to grant the underwriters of the offerings a 30-day option to purchase, in whole or in part, up to $112,500,000 of additional shares of Common Stock in the Common Stock Offering and a 30-day option to purchase, in whole or in part, up to $112,500,000 aggregate principal amount of additional Convertible Notes in the Convertible Notes Offering, in each case solely to cover over-allotments,...

Continue reading

AAC Holdings Gains Support From Lenders, Proceeds With Recapitalization Plan to Support Patient Care & Long-Term Growth

With Treatment Operations Unaffected, AAC Will Continue Providing High-Quality Patient CareCompany Recapitalizes with Initial $62.5M in Incremental Financing & Lower Debt Cost to Better Position the Company and Its Treatment Facilities for Long-Term GrowthAAC & Its Treatment Facilities Positioned for Long-Term GrowthBRENTWOOD, Tenn., June 20, 2020 (GLOBE NEWSWIRE) — AAC Holdings, Inc. (“AAC” or the “Company”) (OTC: AACH), a leading provider of inpatient and outpatient substance abuse treatment services, today announced it has received the support of its Board of Directors and lenders to move forward with a strategic recapitalization plan. The plan is designed to significantly reduce the Company’s debt obligations and establish a sound financial platform for long-term growth, while maintaining AAC’s outstanding standards...

Continue reading

Chicken Soup for the Soul Entertainment Announces Timing of Regular Monthly Dividend for July 2020 for Series A Cumulative Redeemable Perpetual Preferred Stock

COS COB, Conn., June 20, 2020 (GLOBE NEWSWIRE) — Chicken Soup for the Soul Entertainment Inc. (Nasdaq: CSSE, CSSEP), a growing media company building online video on-demand (“VOD”) networks that provide video content for all screens, today announced the timing for the payment of its declared regular monthly dividend of $0.2031 per share of its 9.75% Series A Cumulative Redeemable Perpetual Preferred Stock for July 2020. The dividend will be payable on July 15, 2020 to holders of record as of June 30, 2020. The dividend will be paid in cash.ABOUT CHICKEN SOUP FOR THE SOUL ENTERTAINMENTChicken Soup for the Soul Entertainment Inc. (Nasdaq: CSSE) (the “Company”) operates streaming video-on-demand networks (VOD). The Company owns a majority stake in Crackle Plus, a company formed with Sony Pictures Television, which owns and operates a...

Continue reading

Abildgaard skifter permanent til FC Rubin Kazan

NASDAQ OMX Copenhagen A/SBørsmeddelelse nr. 2020/12Aalborg 20. juni 2020Aalborg Boldspilklub A/S indgik i februar 2020 en lejeaftale med købsoption med den russiske klub FC Rubin Kazan om spilleren Oliver Abildgaard.  Købsoptionen er i dag blevet realiseret, hvorfor Oliver Abildgaard tiltræder hos FC Rubin Kazan på en aftale gældende til 30. juni 2024.Administrerende direktør

Continue reading

BiKi.com Lists Multicoin (MTCN) Token, The First Blockchain E-Commerce Marketplace

Singapore, June 16, 2020 — Global digital assets trading platform BiKi.com is pleased to announce that Multicoin will be listed soon on the exchange. An ERC-20 compliant token, the Multicoin is the sole medium of exchange on the Multiven Open Marketplace (MOM), the world’s first and most advanced blockchain-based marketplace that enables peer-to-peer e-commerce transactions with on-chain proof-of-ownership record. “We are happy to be supporting a project that has shown lots of potential and already has a working PoC (Proof-of-Concept),” says Ethan Ng, CEO of BiKi.com Southeast Asia. “Since coming out of beta in December 2019, the platform has successfully transacted for global consumers from Asia, Europe and Latin America and continues to keep expanding its market.” “As most of the goods on Amazon and AliExpress are made in China,...

Continue reading

Invitation June 29th Online Virtual Family Office and Institutional Investor Luncheon

The Ivy Family Office Network (IVYFON) has assembled a group of subject matter experts on investing in downturns for an online family office and institutional investor luncheon on June 29th from 12 noon eastern time to 3:00 p.m eastern time. There is no fee to participate. We are limiting participation to 300 people and have more than 70 people are registered after a few days of registration availability. The agenda is here – https://ivyfon.com/jun29forum/agenda.html . You can register here – https://ivyfon.com/jun29forum/jun29register.html We have also confirmed that we will be restarting our live / simulcast all day forums on July 28th in Austin, TX, then in August with events in Chicago and San Diego. More information is below. Oliver Wriedt will be the headline speaker for the event. Oliver is Chief Executive Officer of...

Continue reading

SINTX TECHNOLOGIES ANNOUNCES SARS-COV-2 TESTING RESULTS

SALT LAKE CITY, UT, June 20, 2020 (GLOBE NEWSWIRE) — SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an original equipment manufacturer (OEM) ceramics company focused on silicon nitride and its applications, today announced that in a controlled laboratory study, the SARS-CoV-2 virus was inactivated when exposed to SINTX’s sintered silicon nitride powder. The Company expects to share additional data soon, once the findings are published in a rapid-review forum.“The preliminary results are encouraging,” said Dr. Sonny Bal, CEO of SINTX. “The antiviral data are consistent with the well-established anti-bacterial properties of SINTX’s silicon nitride, and with previously reported effectiveness against several single-strand RNA viruses. Additional testing at independent, outside laboratories is in progress to corroborate...

Continue reading

Nabriva Therapeutics Receives Complete Response Letter from FDA on NDA for CONTEPO™ (fosfomycin) for injection

DUBLIN, Ireland, June 19, 2020 (GLOBE NEWSWIRE) — Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, announced today that it received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) for the New Drug Application (NDA) resubmission seeking marketing approval of CONTEPO (fosfomycin) for injection for the treatment of complicated urinary tract infections (cUTI), including acute pyelonephritis. Although Nabriva’s European contract manufacturing partners were prepared for regulatory authority inspections, the CRL cites observations at our manufacturing partners that could not be resolved due to FDA’s inability to conduct onsite inspections because of travel restrictions....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.